Previous Close | 0.9000 |
Open | 0.9000 |
Bid | 0.0500 |
Ask | 4.1000 |
Strike | 110.00 |
Expire Date | 2024-08-16 |
Day's Range | 0.9000 - 0.9000 |
Contract Range | N/A |
Volume | |
Open Interest | 4 |
Nektar (NKTR) reports a narrower-than-expected loss in the first quarter of 2024 and tops revenue estimates.
Insmed (INSM) Q1 earnings beat estimates while sales miss the mark. Management posts positive data readouts from mid-stage studies on its experimental inhalation powder in PH-ILD and PAH indications.
Iovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for the recently-approved melanoma drug Amtagvi in the United States.